ArticleVaccines2023

Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer.

Kodchakorn Mahasongkram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.